REGISTERED
on 06 Aug 2019
Last Applicant/ Owned by
3-5-1, Nihonbashi Honcho, Chuo-ku
Tokyo 103-8426
JP
Serial Number
87918275 filed on 11th May 2018
Registration Number
5824239 registered on 06th Aug 2019
Correspondent Address
Bassam N. Ibrahim
Filing Basis
1. intent to use
Disclaimer
NO DATA
MYADCA
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney di Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 87918275
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 0076404-176
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Aug 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 06th Aug 2019 | REGISTERED-PRINCIPAL REGISTER |
| 21st May 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st May 2019 | PUBLISHED FOR OPPOSITION |
| 01st May 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Apr 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| 12th Apr 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 06th Apr 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Mar 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 25th Mar 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |